Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques
- Research works
- 98 ▲ 3% vs 2013–17
- Citations
- 2.8k 29.1 per fractional work
- Top-10% rate
- 16.3% record average 16.5%
- Open access
- 62% world 28%
Not ranked overall: Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 9.4×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 9.4×
- Neuroscience 5.1×
- Medicine 1.4×
- Immunology and Microbiology 1.0×
- Arts and Humanities 1.0×
- Mathematics 0.7×
- Nursing 0.7×
- Psychology 0.6×
- Environmental Science 0.3×
- Energy 0.2×
- Engineering 0.2×
- Health Professions 0.2×
- Social Sciences 0.2×
- Materials Science 0.1×
- Agricultural and Biological Sciences 0.1×
- Physics and Astronomy 0.0×
Which keywords describe research at Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques?
By fractional works in all years, weighted toward what it does more of than the world: Differentiation, Pluripotent Stem Cells, Transcriptional Regulation, Embryonic Stem Cells, Induced Pluripotent Stem Cells, Reprogramming, Genome Engineering and RNA-Guided.
- Cell Culture
- Therapeutic
- Multipotent
- Muscle Regeneration
- Immunomodulation
- Mesenchymal Stem Cells
- Retinal Stem Cells
- Electrical Stimulation
- Regulatory Challenges
- Brain Development
- Clinical Trials
- Macular Degeneration
- Protein Aggregation
- Regeneration
- Gene Therapy
- Mitochondrial Dysfunction
- RNA-Guided
- Reprogramming
- Embryonic Stem Cells
- Pluripotent Stem Cells
- Differentiation
- Transcriptional Regulation
- Induced Pluripotent Stem Cells
- Genome Engineering
- Regenerative Medicine
- Stem Cells
- Cancer
- Chaperones
- Huntington's Disease
- Polyglutamine
- Ethical Issues
- Genetic Mutations
- Stem Cell Regulation
- Gene Expression
- Retinitis Pigmentosa
- Electrode Arrays
- Neural Stimulation
- Skeletal Muscle Atrophy
- Stromal Cells
- Extracellular Matrix
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Differentiation15▲ 208×2 topics
- Pluripotent Stem Cells15▲ 217×2 topics
- Transcriptional Regulation14▲ 56×5 topics
- Embryonic Stem Cells14▲ 189×2 topics
- Induced Pluripotent Stem Cells13▲ 385×1 topic
- Reprogramming13▲ 385×1 topic
- Genome Engineering7▲ 125×1 topic
- RNA-Guided7▲ 125×1 topic
- Regenerative Medicine6▲ 26×4 topics
- Mitochondrial Dysfunction4▲ 13×7 topics
- Stem Cells4▲ 13×9 topics
- Gene Therapy3▲ 13×4 topics
- Cancer3▲ 2.3×16 topics
- Regeneration3▲ 18×3 topics
- Chaperones3▲ 46×2 topics
- Protein Aggregation3▲ 37×2 topics
- Huntington's Disease3▲ 81×1 topic
- Macular Degeneration3▲ 23×3 topics
- Polyglutamine3▲ 81×1 topic
- Clinical Trials3▲ 4.2×2 topics
- Ethical Issues3▲ 28×2 topics
- Brain Development2▲ 13×4 topics
- Genetic Mutations2▲ 4.8×11 topics
- Regulatory Challenges2▲ 33×1 topic
- Stem Cell Regulation2▲ 113×1 topic
- Electrical Stimulation2▲ 38×2 topics
- Gene Expression2▲ 4.0×9 topics
- Retinal Stem Cells2▲ 60×1 topic
- Retinitis Pigmentosa2▲ 60×1 topic
- Mesenchymal Stem Cells2▲ 19×2 topics
- Electrode Arrays2▲ 38×1 topic
- Immunomodulation2▲ 14×2 topics
- Neural Stimulation2▲ 38×1 topic
- Muscle Regeneration2▲ 57×1 topic
- Skeletal Muscle Atrophy2▲ 57×1 topic
- Multipotent2▲ 50×1 topic
- Stromal Cells2▲ 22×2 topics
- Therapeutic2▲ 24×1 topic
- Extracellular Matrix2▲ 7.4×4 topics
- Cell Culture2▲ 16×2 topics
Which research topics does Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques publish most on?
By volume in 2022–2025: Pluripotent Stem Cells Research, Muscle Physiology and Disorders, CRISPR and Genetic Engineering and Biochemical and Molecular Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Pluripotent Stem Cells Research Molecular Biology 2 works
- 2 Muscle Physiology and Disorders Molecular Biology 1 works
- 3 CRISPR and Genetic Engineering Molecular Biology 1 works
- 4 Biochemical and Molecular Research Molecular Biology 1 works
- 5 Cytomegalovirus and herpesvirus research Epidemiology 0 works
- 6 Genetics and Neurodevelopmental Disorders Genetics 0 works
- 7 Neurogenetic and Muscular Disorders Research Genetics 0 works
- 8 Wound Healing and Treatments Rehabilitation 0 works
- 9 Skin and Cellular Biology Research Cell Biology 0 works
- 10 Cardiomyopathy and Myosin Studies Cardiology and Cardiovascular Medicine 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institut des Cellules Souches pour le Traitement et l'Étude des Maladies Monogéniques's research output changed?
Output in 2018–2022 was 3% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Évry-Courcouronnes
- Centre des Matériaux
- Arianespace (France)
- Genethon (France)
- Genoscope
- Genopole (France)
- École Nationale Supérieure d’Informatique pour l’Industrie et l’Entreprise
- Institut de Biologie systémique et synthétique
- Santen (France)
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.